Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/21/2009 | CN101348783A Method for preparing Saccharomyces cerevisiae product using aerospace biological technology and product thereof |
01/21/2009 | CN101348776A Transgenic lactobacillus secreting acidic cellulase, preparation and use thereof |
01/21/2009 | CN101348775A Enterobacteria recombinant strain and use thereof |
01/21/2009 | CN101348769A H+-ATP enzyme acid resistant gene atpAí» and Lactobacillus casei containing the same |
01/21/2009 | CN101348763A Apparatus for polynucleotide detection and quantitation |
01/21/2009 | CN101348526A Anti-interleukin-8 antibody |
01/21/2009 | CN101348525A Anti-schistosomiasis monoclonal antibody NP11-4 single-chain antibody, preparation and use thereof |
01/21/2009 | CN101348523A Plants cold-tolerant and drought resisting protein, encoding genes and use thereof |
01/21/2009 | CN101348522A Copper resistance binary signal conducting system regulation factor mutant, and construction and use thereof |
01/21/2009 | CN101348512A Antineoplastic ad virus preparation |
01/21/2009 | CN100453649C Method of changing color of ornamental plant leaf colour flower using plant DNA virus reticent currier |
01/21/2009 | CN100453648C The pET15b-PEP-1-Cat plasmid and its construction and PEP-1-CAT fusion protein and its expression |
01/21/2009 | CN100453647C DNA vaccine carrier of carring SV40 enhancer element |
01/21/2009 | CN100453646C Gene sequence of beta-mannase and process for preparing recombinant enzyme coded by it |
01/21/2009 | CN100453645C Antibodies against insulin-like growth factor i receptor and uses thereof |
01/21/2009 | CN100453644C Method for femtosecond laser fusion of phaffiafhodozyma cell |
01/21/2009 | CN100453643C Purification method of human glutathione-s-transferase Pi and application of said enzyme |
01/21/2009 | CN100453556C Multispecific deimmunized CD3-binders |
01/21/2009 | CN100453555C Paddy rice fragile straw controlling gene BC1 and use thereof |
01/20/2009 | USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes |
01/20/2009 | US7479586 Plants and seeds of corn variety I285282 |
01/20/2009 | US7479585 Plants and seeds of corn variety I774019 |
01/20/2009 | US7479584 Methods and compositions for modulating flowering and maturity in plants |
01/20/2009 | US7479581 Soybean variety XB40K07 |
01/20/2009 | US7479579 Genetically engineered rodent comprisingamyloid precursor protein mutation for use as tool in screening therapeutic agents for treatment of neurodegenerative diseases |
01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
01/20/2009 | US7479555 Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity |
01/20/2009 | US7479554 AAV5 nucleic acids |
01/20/2009 | US7479552 Type-1 ribosome-inactivating protein |
01/20/2009 | US7479549 Recombinant canine thyroid stimulating hormone and methods of production and use thereof |
01/20/2009 | US7479547 Using shuffled viral protein sequences as tool in generating antibodies for diagnosis, prevention and treatment of viral disease |
01/20/2009 | US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
01/20/2009 | US7479544 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs |
01/20/2009 | US7479543 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
01/20/2009 | US7479542 polymer conjugated drug contains polyethylene glycol covalently attached to the polypeptide; biodrug for treating hepatitis C; new kind of interleukins; fusion proteins |
01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
01/20/2009 | US7479539 Hedgehog fusion proteins |
01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
01/20/2009 | US7479472 DNA-templated combinatorial library chemistry |
01/20/2009 | US7479389 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2) |
01/20/2009 | US7479387 Host cell transformed with recombinant enzymes from Arabidopsis thaliana to synthesize 6-sulfo-alpha-D-quinovosyl diaclyglycerol (SQDG) also called sulfoquinovosyldiacylglycerol, KM043 which is a polymerase inhibitor drug; sqdX gene for example |
01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
01/20/2009 | US7479385 Sugar kinases with expanded substrate specificity and their use |
01/20/2009 | US7479384 Nematode MDH-like sequences |
01/20/2009 | US7479383 Mutant PQQGDH has less dehydrogenase activity on a disaccharide than wild type PQQGDH, more thermal stability; glucose sensor for use in clinical laboratory tests and food analysis |
01/20/2009 | US7479382 Vectors, host cells; use screening for nematocides; environmentally safe, target-specific ways of controlling plant parasitic nematodes |
01/20/2009 | US7479379 Methods for altering protein production rates |
01/20/2009 | US7479377 Genetic construct intracellular monitoring system |
01/20/2009 | US7479376 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
01/20/2009 | US7479374 Triacylglycerol-deficient fission yeast and its uses |
01/20/2009 | US7479373 Method for identifying compounds modulating taste transduction |
01/20/2009 | US7479369 using a nucleic acid molecule in a screening assay for the identification of antiproliferative drug, and performing a functional analysis for the spindle formation or microtubule function during cell division; small interfering RNAs |
01/20/2009 | US7479284 Babesia canis vaccine |
01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
01/20/2009 | US7479278 Troponin I polypeptide fragments and uses thereof |
01/20/2009 | US7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
01/20/2009 | US7479275 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
01/20/2009 | US7479274 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
01/20/2009 | US7479273 Method of administering and using VEGF inhibitors for the treatment of renal cell cancer |
01/20/2009 | US7479272 Method of administering and using VEGF inhibitors for the treatment of breast cancer |
01/20/2009 | US7479256 Device that simultaneously and accurately applies microdroplets to a substrate in a regular pattern; a pressure chamber is filled with a buffer medium arranged so that medium can simultaneously be used for applying pressure to the liquid-column ends that are spaced apart from the nozzle orifices |
01/20/2009 | CA2379773C Device and method for mixing magnetic particles with a fluid |
01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
01/20/2009 | CA2308368C Specific and sensitive nucleic acid detection method |
01/20/2009 | CA2258512C Amidases, nucleic acids encoding them and methods for making and using them |
01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
01/20/2009 | CA2192364C Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
01/20/2009 | CA2137822C Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
01/15/2009 | WO2009009798A2 Allelic exchange mutagenesis in map |
01/15/2009 | WO2009009589A2 System and methods for normalizing data in nucleic acid amplification procedures |
01/15/2009 | WO2009009142A2 Transgenic plants with enhanced agronomic traits |
01/15/2009 | WO2009009084A2 Transcriptional engineering of lactobacillus |
01/15/2009 | WO2009008888A1 African swine virus polypeptides as vaccines and its therapeutic use thereof |
01/15/2009 | WO2009008837A1 Lexa-based chemical-inducible gene expression system for use in transgenic animals |
01/15/2009 | WO2009008713A1 Tap-inhibitors from old world primate 1-herpesviruses and their use |
01/15/2009 | WO2009008645A2 Linear double-stranded rna molecule interfering with different target genes |
01/15/2009 | WO2009008574A1 Homo-succinic acid producing microorganism variant and process for preparing succinic acid using the same |
01/15/2009 | WO2009008573A1 An avian influenza virus vaccine and a method for preparing same |
01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |
01/15/2009 | WO2009008466A1 Phosphatidate phosphatase homolog and use of the same |
01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
01/15/2009 | WO2009008412A1 Dna chip for prediction of occurrence of late adverse reaction in urinary organ after radiation therapy, and method for prediction of occurrence of late adverse reaction in urinary organ after radiation therapy using the same |
01/15/2009 | WO2009008377A1 Isopropyl alcohol-producing bacterium and method of producing isopropyl alcohol using the same |
01/15/2009 | WO2009008374A1 Method for acquiring biological rhythm information |
01/15/2009 | WO2009007982A1 A conserved region of the hiv-1 genome and uses thereof |
01/15/2009 | WO2009007980A1 Nucleic acid construct systems capable of diagnosing or treating a cell state |
01/15/2009 | WO2009007855A2 Reversible sirna-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of huntington's disease |
01/15/2009 | WO2009007848A2 Bioactive peptides and method of using same |
01/15/2009 | WO2009007714A2 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
01/15/2009 | WO2009007510A1 Novel esterases and their use |
01/15/2009 | WO2009007503A1 Delivery of nucleic acids into genomes of human stem cells using in vitro assembled mu transposition complexes |
01/15/2009 | WO2009007244A2 Replication deficient influenza virus for the expression of heterologous sequences |
01/15/2009 | WO2009007192A1 A bile resistant bacillus composition secreting high levels of phytase |
01/15/2009 | WO2009007120A2 Tnf superfamily collectin fusion proteins |
01/15/2009 | WO2009007091A2 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
01/15/2009 | WO2009006997A1 Human pluripotent stem cells and their medical use |